Clinical Trial Update: S-1 and Photodynamic Therapy in Cholangiocarcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating S-1 with photodynamic therapy for cholangiocarcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Asan Medical Center | Conditions: Cholangiocarcinoma | Phase 3 | Status: COMPLETED